NRX Pharmaceuticals, Inc. (NRXP)
1.84
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 16:00
1.85
+0.01
(+0.54%)
After-Hours: 20:00
NRX Pharmaceuticals Total Liabilities (Quarterly) : 40.75M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Synergy CHC Corp. | 28.94M |
| Acurx Pharmaceuticals, Inc. | 2.468M |
| NeOnc Technologies Holdings, Inc. | 15.90M |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Agenus, Inc. | 514.76M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.00M |
| Shareholders Equity (Quarterly) | -25.76M |
| Debt to Equity Ratio | -0.4041 |
| Current Ratio | 0.2943 |
| Net Debt Paydown Yield | -0.40% |